Literature DB >> 25796773

[Idiopathic pulmonary fibrosis].

J Guiot, J L Corhay, R Louis.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is one of the multiple pathologies included in the large family of diffuse interstitial parenchymal lung diseases (IPD). The latter represent a large group of about 200 different diseases, most of which are orphan diseases. Recently, some new therapeutic options have appeared that require an early and accurate diagnosis of pulmonary fibrosis.

Entities:  

Mesh:

Year:  2014        PMID: 25796773

Source DB:  PubMed          Journal:  Rev Med Liege        ISSN: 0370-629X


  4 in total

1.  Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis.

Authors:  J Guiot; I Struman; V Chavez; M Henket; M Herzog; K Scoubeau; N Hardat; B Bondue; J L Corhay; C Moermans; R Louis
Journal:  Clin Epigenetics       Date:  2017-08-15       Impact factor: 6.551

Review 2.  Exosomal Long Non-Coding RNAs in Lung Diseases.

Authors:  Christophe Poulet; Makon-Sébastien Njock; Catherine Moermans; Edouard Louis; Renaud Louis; Michel Malaise; Julien Guiot
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

3.  Syringic and ascorbic acids prevent NDMA-induced pulmonary fibrogenesis, inflammation, apoptosis, and oxidative stress through the regulation of PI3K-Akt/PKB-mTOR-PTEN signaling pathway.

Authors:  Oluwatobi T Somade; Olubisi E Adeyi; Babajide O Ajayi; Osiro O Asunde; Precious D Iloh; Adedayo A Adesanya; Olanrewaju I Babalola; Oluwaseyi T Folorunsho; Deborah A Olakunle; Opeyemi F Lawal
Journal:  Metabol Open       Date:  2022-03-17

4.  Impact of interstitial lung disease on postoperative morbidity and 90-day mortality after pulmonary resection.

Authors:  Weipeng Shao; Jingjing Huang; Hongxiang Feng; Hongliang Sun; Yanhong Ren; Xiaowei Wang; Zhenrong Zhang; Deruo Liu
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.